Tandem Diabetes Care | سود ناخالص در فروش



Gross Profit On Sales تغییر دادن تاریخ
Abbott USD 5.87B 50M 2025-06
Align Technology USD 708.12M 28.01M 2025-06
AtriCure USD 101.48M 8.85M 2025-06
Baxter International USD 1.14B 283M 2025-06
Becton, Dickinson and Co. USD 2.63B 377M 2025-06
Boston Scientific USD 3.42B 228M 2025-06
Cooper Companies USD 679.1M 18.9M 2025-04
Dexcom USD 688.8M 99.8M 2025-06
Edwards Lifesciences USD 1.19B 76.7M 2025-06
Eli Lilly USD 10.5B 624.7M 2025-03
Globus Medical USD 1.21B 809.01M 2025-06
ICU Medical USD 208.06M 2.04M 2025-06
Insulet USD 452.2M 43.2M 2025-06
Integra LifeSciences USD 209.33M 5.81M 2025-06
Intuitive Surgical USD 1.62B 160.2M 2025-06
J&J USD 14.6B 816M 2025-03
Masimo USD 233.3M 700K 2025-06
Medtronic USD 5.81B 296M 2025-04
Merit Medical Systems USD 184.49M 12.47M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Stryker USD 3.84B 30M 2025-06
Tandem Diabetes Care USD 125.85M 7.45M 2025-06
Teleflex USD 431.08M 41.65M 2025-06
Zimmer Biomet Holdings USD 1.32B 34.8M 2025-06


Tandem Diabetes Care سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Aug 2025.